A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 9/127 (2006.01) A61K 31/70 (2006.01) C07H 21/00 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2248932
Oligonucleotides, and compositions thereof, are disclosed which can be administered to human subjects to inhibit the expression of angiotensinogen to thereby control angiotensinogen induced hypertension.
L'invention concerne des oligonucléotides et des compositions de ces derniers qui peuvent être administrés à l'homme pour inhiber l'expression de l'angiotensinogène. Cela permet ainsi de combattre l'hypertension induite par l'angiotensinogène.
Phillips M. Ian
Wielbo Donna
Deeth Williams Wall Llp
Phillips M. Ian
University Of Florida
Wielbo Donna
LandOfFree
Oligonucleotides targeted to angiotensinogen mrna does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides targeted to angiotensinogen mrna, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides targeted to angiotensinogen mrna will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1833775